JETi™ Thrombectomy System Clinical Evidence

An Overview of Clinical Studies

JETi Thrombectomy System Clinical Data

The JETi™ Thrombectomy System fragments and aspirates clot1 for single-session efficiency and outcomes2

As shown in the three studies presented below, the JETi™ System demonstrates positive clinical outcomes in a variety of thrombosis cases.

Treatment of Symptomatic Venous Thrombosis

Single-session treatment of patients with symptomatic venous thrombosis

Razavi et al., JVIR. 2021.

Prospective study investigating single-session treatment of iliocaval and iliofemoral venous thrombosis while evaluating potential for treatment on an outpatient basis.

Learn More About JETi Clinical Evidence

Single-session treatment of lower extremity venous thrombosis using a novel thrombectomy device

Khalsa et al., JVIR. 2020.

Retrospective review of 30 patients treated with JETi for acute lower extremity venous thrombosis.

Learn More About JETi Clinical Evidence

Percutaneous thrombectomy with the JETi™ Peripheral Thrombectomy System for the treatment of venous thrombosis

Cournoyer-Rodrigue et al., JVIR. 2019.

Retrospective evaluation of 18 consecutive acute venous thrombosis patients at a new JETi user facility.

Learn More About JETi Clinical Evidence


  1. JETi™ Thrombectomy System Instructions for Use (IFU). Refer to IFU for additional information.
  2. Cournoyer-Rodrigue et al., JVIR. 2019

MAT-2202242 v1.0